Hogan Lovells Advises Fresenius Kabi on Anápolis Site Transfer

Deal News | Apr 11, 2025 | Hogan Lovells

Hogan Lovells has provided legal advice to Fresenius Kabi on the transfer of its Anápolis production site and Goiânia logistics operation in Brazil to EMS. This transaction is part of Fresenius Kabi's broader global strategy to optimize its production network and improve operational efficiency. Despite this transfer, Fresenius Kabi will maintain a significant presence in Brazil, focusing on its Biopharma, Nutrition, Pharma, and MedTech divisions, thereby reiterating its dedication to delivering high-quality healthcare solutions. The legal aspects of this deal were handled by Hogan Lovells' multidisciplinary team, involving corporate and life sciences expertise. Approval from relevant regulatory authorities is still pending.

Sectors

  • Healthcare Manufacturing
  • Legal Services

Geography

  • Brazil – The transaction involves the transfer of operations from Fresenius Kabi to EMS within Brazil, specifically in Anápolis and Goiânia.
  • Germany – Fresenius Kabi is a German company, with legal advisory services provided by Hogan Lovells' German offices.

Industry

  • Healthcare Manufacturing – The industry is relevant as Fresenius Kabi is involved in the production and manufacturing of healthcare products including biopharma, nutrition, and medtech.
  • Legal Services – Hogan Lovells provides the necessary legal services to facilitate the transaction between Fresenius Kabi and EMS.

Financials

    Participants

    NameRoleTypeDescription
    Fresenius KabiSelling CompanyCompanyA global healthcare company focusing on Biopharma, Nutrition, Pharma, and MedTech.
    EMSTarget CompanyCompanyThe acquiring company for the Anápolis production site and logistic operations in Goiânia.
    Hogan LovellsLegal AdvisorCompanyInternational law firm advising Fresenius Kabi on the transaction.